Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-operative Vaginal Misoprostol in Open Myomectomy
NCT03509168Phase 3Unknown
- Sponsor
- Makerere University
- Start
- Jan 2018
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of misoprostol in Uterine Fibroids (UF) (2 arms), sponsored by Makerere University. Primary endpoint: Intraoperative blood loss during open myomectomy. Status: unknown.
02
Drugs
misoprostol
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT03509168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03509168.